- Home
- CRNT vs CRBU Comparison
CRNT vs CRBU Comparison
Compare CRNT & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNT | CRBU |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 203.9M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRNT | CRBU |
|---|---|---|
| Price | $2.19 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.00 | ★ $9.33 |
| AVG Volume (30 Days) | 550.5K | ★ 981.0K |
| Earning Date | 02-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $363,330,000.00 | $9,295,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.06 | $3.62 |
| P/E Ratio | $140.03 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.82 | $0.66 |
| 52 Week High | $5.73 | $3.54 |
Technical Indicators
Market Signals| Indicator | CRNT | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 36.37 |
| Support Level | $2.05 | $1.63 |
| Resistance Level | $2.15 | $1.73 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 97.92 | 14.93 |
Price Performance
Historical ComparisonAbout CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.